Literature DB >> 22018445

Does increase in utilisation rates alone indicate the success of a user fee removal policy? A qualitative case study from Zambia.

Mary Hadley1.   

Abstract

OBJECTIVE: To provide more comprehensive understanding of utilisation of health facilities in the context of user fee removal policy with a focus on local practices.
METHODS: A wide range of stakeholders were included in in-depth interviews, group discussions and observations at sites where user fees had been removed and those still charging.
RESULTS: Success of a user fee removal policy is typically measured in terms of utilisation. The focus of this study was on the local context of attendance rather than statistical trends. The results show that even after removal of user fees ill people were denied health care due to known barriers of distance, staff attitudes, waiting times and additional costs. Frivolous use and sharing of medicines in the community further compromised the success of the user fee removal policy.
CONCLUSION: Utilisation rates as a statistical indicator are not sufficient to assess the success or failure of user fee policies in improving health outcomes. Qualitative insight into local health care practices is required to understand how (removal of) user fees affect both individuals and communities. Further research in remaining barriers to access, frivolous use, treatment and adherence to medical advice is required. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018445     DOI: 10.1016/j.healthpol.2011.08.009

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  9 in total

1.  Does Free Public Health Care Increase Utilization and Reduce Spending? Heterogeneity and Long Term Effects.

Authors:  Peter Hangoma; Bjarne Robberstad; Arild Aakvik
Journal:  World Dev       Date:  2017-07-04

2.  An assessment of the effect of user fee policy reform on facility-based deliveries in rural Zambia.

Authors:  Chitalu Miriam Chama-Chiliba; Steven Fredric Koch
Journal:  BMC Res Notes       Date:  2016-12-07

3.  Treatment-seeking behaviour in low- and middle-income countries estimated using a Bayesian model.

Authors:  Victor A Alegana; Jim Wright; Carla Pezzulo; Andrew J Tatem; Peter M Atkinson
Journal:  BMC Med Res Methodol       Date:  2017-04-20       Impact factor: 4.615

4.  Integration of eye health into primary care services in Tanzania: a qualitative investigation of experiences in two districts.

Authors:  Emma Jolley; Milka Mafwiri; Joanna Hunter; Elena Schmidt
Journal:  BMC Health Serv Res       Date:  2017-12-13       Impact factor: 2.655

Review 5.  Building a middle-range theory of free public healthcare seeking in sub-Saharan Africa: a realist review.

Authors:  Emilie Robert; Oumar Mallé Samb; Bruno Marchal; Valéry Ridde
Journal:  Health Policy Plan       Date:  2017-09-01       Impact factor: 3.344

6.  How effective and fair is user fee removal? Evidence from Zambia using a pooled synthetic control.

Authors:  Aurélia Lépine; Mylène Lagarde; Alexis Le Nestour
Journal:  Health Econ       Date:  2017-10-16       Impact factor: 3.046

Review 7.  Examining vulnerability and resilience in maternal, newborn and child health through a gender lens in low-income and middle-income countries: a scoping review.

Authors:  Fatima Abdulaziz Sule; Olalekan A Uthman; Emmanuel Olawale Olamijuwon; Nchelem Kokomma Ichegbo; Ifeanyi C Mgbachi; Babasola Okusanya; Olusesan Ayodeji Makinde
Journal:  BMJ Glob Health       Date:  2022-04

Review 8.  From institutionalization of user fees to their abolition in West Africa: a story of pilot projects and public policies.

Authors:  Valéry Ridde
Journal:  BMC Health Serv Res       Date:  2015-11-06       Impact factor: 2.655

9.  Assessing regional variations in the effect of the removal of user fees on facility-based deliveries in rural Zambia.

Authors:  Chama-Chiliba Chitalu; Koch Steven
Journal:  Afr Health Sci       Date:  2017-12       Impact factor: 0.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.